NUTX Nutex Health Inc.

Nutex Health (NUTX) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

Nutex Health has become a high profile healthcare stock after a very large 3 year return, and the question now is whether that market price lines up with what the business is earning. With the move influenced by both operational progress and fresh risks, the key issue for anyone looking at Nutex Health is how much of its earnings power is already reflected in the current valuation. Over the past 3 years Nutex Health has delivered a very large share price gain, which puts extra pressure on...

Nutex Health (NUTX) just secured approval to dual-list its common stock on Nasdaq Texas, with trading expected to begin around September 23, 2026. This move may broaden liquidity and investor access. Recent trading has been choppy for Nutex Health, with the share price slipping 3.33% over the last day and 5.81% across the past week, even after a 30 day share price return of 7.32% and a 90 day gain of 21.31%, which leaves momentum still positive overall. Look beyond Nutex Health and review how...

EuroDry, Vince Holding, Nutex, TXO Partners and KB Financial have been highlighted in this Screen of The Week article.

EDRY, VNCE, NUTX, TXO and KB show strong recent price momentum despite a volatile September, backed by improving earnings expectations.

Sometimes thinly traded or low-priced stocks can be institutional quality when it comes to their average daily dollar volume.

Nutex Health (NUTX) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

Honeywell Aerospace settles cyber whistleblower case; CrowdStrike helps law enforcement take down botnet.

Does Nutex Health Inc. (NUTX) have what it takes to be a top stock pick for momentum investors? Let's find out.

Nutex, RCM, Remitly and Belden have been highlighted in this Screen of The Week article.

NUTX, RCMT, RELY and BDC boast strong net margins, positive earnings estimate revisions and bullish analyst ratings that signal upside.

Nutex Health (NUTX) has drawn fresh attention after announcing the opening of its 28th hospital nationwide. The new West Little Rock Emergency Hospital facility in Arkansas offers advanced imaging and full-service lab capabilities. That expansion comes as Nutex Health’s share price shows strong momentum, with a 1 month share price return of 31.76% and a 90 day share price return of 50.04%. This has contributed to a 1 year total shareholder return of 118.22% and a 3 year total shareholder...

Nutex Health stock has delivered very strong returns over the past three years, yet the broader valuation checks point to a mixed picture rather than a clear bargain or an obviously overpriced stock. After such a sharp move, investors are weighing how much of the recent optimism is already reflected in the share price. The 3 year return of about 318.5% is very large and puts extra focus on whether recent gains can be supported by the company’s fundamentals. Nutex Health’s recent public...

Nutex Health (NUTX) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

Quantum computers exist mainly in labs but “Q-day”—the hypothetical moment when quantum computers become powerful enough to break standard-key encryption—is coming. WSJ takes a look at the state of this emerging technology. Websites purporting to offer demo versions of the forthcoming “Grand Theft Auto” version VI are snaring gamers in malware, according to cybersecurity company Malwarebytes.

Nutex Health Inc. (NUTX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

The average of price targets set by Wall Street analysts indicates a potential upside of 47.1% in Nutex Health (NUTX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Nutex Health Inc (NUTX) posts record profitability in Q2 2026, driven by lower arbitration costs and strong operational execution despite a 13.6% revenue dip.

Net income surged $65.8M as contract costs fell and volumes climbed.

Nutex Health (NASDAQ:NUTX) reported higher second-quarter profitability and adjusted EBITDA despite lower revenue, as the company benefited from reduced arbitration-related costs, lower stock-based compensation and continued patient-volume growth. For the three months ended June 30, Nutex reported

Moby summary of Nutex Health, Inc.'s Q2 2026 earnings call